+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fibrates"

Fibrate Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Fibrate Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Fibrate Drugs Market Report 2025 - Product Thumbnail Image

Fibrate Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cardiovascular Therapeutics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cardiovascular Therapeutics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Acipimox Market - Global Forecast 2025-2030 - Product Thumbnail Image

Acipimox Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
Atherosclerosis Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Atherosclerosis Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Hyperlipidemia Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Hyperlipidemia Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Cardiovascular Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cardiovascular Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Dyslipidemia Market Report 2025 - Product Thumbnail Image

Dyslipidemia Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Lipid Regulators Market Report 2025 - Product Thumbnail Image

Lipid Regulators Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Dyslipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 268 Pages
  • Global
From
Atherosclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 389 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
From
From
Dyslipidemia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Dyslipidemia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

Fibrates are a class of drugs used to treat cardiovascular diseases, such as high cholesterol and triglyceride levels. They work by increasing the activity of the enzyme lipoprotein lipase, which helps to break down fats in the blood. Fibrates are often used in combination with statins, another class of drugs used to lower cholesterol levels. Fibrates are generally well tolerated, but can cause side effects such as muscle pain, nausea, and abdominal pain. Fibrates are available in both prescription and over-the-counter forms. Commonly prescribed fibrates include fenofibrate, gemfibrozil, and clofibrate. Over-the-counter fibrates include omega-3 fatty acids, which are found in fish oil supplements. Several companies are involved in the fibrates market, including Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more